AlphAIalphai — Financial news for AI agents
orthospinenews.comAUG 54 min read$ATEC

ATEC Reports Second Quarter Financial Results – Ortho Spine News

Alphatec Holdings (Nasdaq: ATEC) reported Q2 2026 revenue of $214 million, up 15% year over year. Surgical revenue was $196 million, up 17%, driven by 20% case volume growth. Adjusted EBITDA was $36 million, 17% of revenue. The company reaffirmed its 2026 outlook: revenue about $882 million and adjusted EBITDA about $140 million.

Original reporting
orthospinenews.com
Published Aug 5, 2026, 12:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 12:55 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
ATEC Reports Second Quarter Financial Results – Ortho Spine News — source image
Source · orthospinenews.com
Decision brief

The 30-second read

$ATECBullishMed
01

Why it matters

Traders can update models around operating leverage (adjusted EBITDA margin up 420 bps) and cash generation (positive free cash flow, TTM free cash flow positivity) while monitoring the webcast for any additional detail not included in the excerpt.

02

Market read

A company-specific earnings and guidance update with raised adjusted EBITDA and continued surgical case volume growth, likely driving near-term positioning into the webcast.

03

What to watch

The excerpt emphasizes non-GAAP adjusted EBITDA and free cash flow positivity, but does not provide GAAP earnings, segment margins, or any litigation updates that could affect quality of earnings.

Relevance 8/10Novelty 7/10Timing: pre-market today, with a live webcast at 1:30 p.m. PT / 4:30 p.m. ET

Background

Alphatec Holdings (ATEC) is a spine-focused surgical solutions provider; this is its Q2 2026 results release with full-year outlook reaffirmation and adjusted EBITDA guidance increase.

Company-level read

Ticker impact

$ATECBullishMedium confidence
Context

ATEC reported Q2 revenue of $214M (+15% YoY), surgical revenue $196M (+17%), and raised full-year adjusted EBITDA guidance to ~$140M.

Expected impact

Moderate upside bias for near-term trading as guidance is increased and profitability metrics improved.

Evidence & confidence

The article provides multiple concrete operating metrics (revenue, surgical growth, adjusted EBITDA margin, free cash flow positivity) plus a specific guidance increase, which typically supports sentiment and positioning ahead of the webcast.

Market effects

Sector

Signals continued demand and adoption in spine surgery technology, potentially supportive for other spine-focused medtech names.

Regional

Limited direct regional spillover; primarily company-specific medtech sentiment.

Global

Low global macro linkage; relevance mainly to US-listed medtech investors.

Counterpoint

What could challenge this read

Revenue outlook is only reaffirmed, so upside may be capped if investors expected a larger top-line upgrade or clearer EPS/GAAP profitability detail.

Key entities

  • company
    Alphatec Holdings, Inc.

    Reported Q2 2026 financial results and reaffirmed 2026 revenue outlook while increasing adjusted EBITDA guidance.

  • executive
    Pat Miles

    CEO/Chairman quoted on case volume growth, surgeon adoption, and profitability.

Read at source← All news

Related articles

AUG 16
$ATECMedAI 8/10

Alphatec (ATEC) Q2 2026 Earnings Call Transcript

Alphatec Holdings (NASDAQ:ATEC) reported Q2 2026 revenue of $214 million, up 15% year over year, with surgical revenue at $196 million, up 17%. Adjusted EBITDA rose to $36 million, up 53%, with GAAP gross margin 72.2%. Management reaffirmed full-year revenue guidance near $882 million and raised adjusted EBITDA guidance to about $140 million.

aol.com6 min
AUG 12
$ATECMed

Alphatec (ATEC) Q2 2026 Earnings Call Transcript

Alphatec Holdings (ATEC) reported Q2 2026 revenue of $214 million, up 15% year over year, with surgical revenue at $196 million, up 17%. Adjusted EBITDA rose 53% to $36 million, and GAAP gross margin was 72.2%. Management reaffirmed full-year revenue guidance near $882 million and raised adjusted EBITDA guidance to about $140 million.

fool.com7 min
AUG 6
$ATECMed

Alphatec Holdings, Inc. Q2 2026 Earnings Call Summary

Alphatec Holdings (ATEC) reported Q2 2026 results driven by 24% growth in new surgeon adoption and 20% procedural volume growth, lifting revenue 15%. Management kept full-year surgical revenue guidance at $805M and raised adjusted EBITDA guidance to $140M. It expects Q3 free cash flow of $4M to $6M and cites margin gains from inventory and supply chain efficiency.

yahoo.com6 min
AUG 4
$ATECMed

Alphatec Holdings, Inc. (ATEC): Results of Operations and Financial Condition

Alphatec Holdings, Inc. (ATEC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 ATEC Reports Second Quarter Financial Results Total revenue of $214 million, up 15% year-over-year Surgical revenue of $196 million increased 17%, driven by 20% case volume growth Company reaffirms 2026 revenue outlook CARLSBAD, Calif., August 4, 2026 – Alphatec Hold

SEC EDGAR 8-K6 min
JUN 1
$ATECMedAI 8/10

Here is Why Alphatec (ATEC) is One of the Best Cheap Stocks Under $10 to Buy in June

Alphatec Holdings (ATEC) reported Q1 2026 results on May 5, with total revenue up 14% to $192 million and surgical revenue up 17%. The company posted non-GAAP adjusted EBITDA of $21 million and said a new bank facility would cut annual interest expense by over $6 million and extend maturities to 2031. For 2026, it expects revenue of about $882 million and adjusted EBITDA of about $134 million.

finance.yahoo.com4 min